Biostar Pharma (BSPM) Posts Lower Q3 Profit
Tweet
Share
E-mailGet Alerts BSPM Hot Sheet
Join SI Premium – FREE
Biostar Pharma (NASDAQ: BSPM) reported Q3 EPS of $0.02, versus $0.03 reported last year. Revenue for the quarter came in at $14.65 million, versus $15.01 million reported last year.
For earnings history and earnings-related data on Biostar Pharma (BSPM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
- Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
